Kiren Mitruka, Manish Bamrotiya, Reshu Agarwal, Anwar Parvez, Ramesh Reddy Allam, Srilatha Sivalenka, Pramod Deoraj, Rajendra Prasad, Uma Devi, Padmaja Keskar, Shrikala Acharya, Priya Kannan, Ramesam Ganti, Malay Shah, Shashikant Todmal, Praveen Kumar, Nalini Chava, Ajit Rao, Sukarma Tanwar, Melissa Nyendak, Tedd Ellerbrock, Timothy H Holtz, R S Gupta
Since September 2015, the World Health Organization has recommended antiretroviral therapy (ART) for all persons with human immunodeficiency virus (HIV) infection, regardless of clinical stage or CD4 count (1). This Treat All policy was based on evidence that ART initiation early in HIV infection as opposed to waiting for the CD4 count to decline to certain levels (e.g., <500 cells/mm3 , per previous guidelines), was associated with reduced morbidity, mortality, and HIV transmission (2-4). Further, approximately half of persons enrolled in non-ART care that included monitoring for HIV disease progression (i...
November 30, 2018: MMWR. Morbidity and Mortality Weekly Report